Clinical Trial Update: Efficacy and Tolerability of Saxagliptin add-on Compared to Uptitration of Metformin in Patients With Type 2 Diabetes [Phase 4]

View source ↗

Summary

Phase 4 study evaluating saxagliptin added to metformin versus uptitration of metformin in adults with Type 2 diabetes, focusing on efficacy and tolerability.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Saxagliptin (Onglyza) (saxagliptin)
• metformin (metformin)

Snippet

Sponsor: AstraZeneca | Conditions: Type 2 Diabetes Mellitus | Phase 4 | Status: COMPLETED | Results posted: 2012-01-05